To validate our findings, we examined the expression profile of SLC7A11 in several clinical variables using GEO datasets, which confirmed its higher expression in advanced clinicopathological stages and cancer tissues (Figures 6N–P). The gene discussed is SLC7A11; the disease is cancer.